tiprankstipranks
Trending News
More News >
Simcere Pharmaceutical Group Limited (HK:2096)
:2096
Hong Kong Market

Compare Simcere Pharmaceutical Group Limited (2096) vs. Competitors

Compare
4 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Simcere Pharmaceutical Group Limited
HK$11.69
HK$30.34B
30.28
70.66%
2 Buy
0 Hold
0 Sell
Moderate Buy
InnoCare Pharma Ltd.
HK$11.72
HK$17.52B
-83.00
111.97%
4 Buy
1 Hold
0 Sell
Strong Buy
Shanghai Junshi Biosciences Co., Ltd. Class H
HK$21.38
HK$36.44B
-20.84
94.36%
0 Buy
1 Hold
0 Sell
Hold
Everest Medicines Ltd.
HK$51.50
HK$13.78B
-17.77
-3.33%
Shanghai Henlius Biotech, Inc. Class H
HK$58.60
HK$31.14B
34.99
241.89%
Ascentage Pharma Group International
HK$50.90
HK$17.81B
-12.27
41.68%
1 Buy
0 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
HK:2096
Simcere Pharmaceutical Group Limited
11.69
4.88
71.66%
HK:9969
InnoCare Pharma Ltd.
11.72
6.15
110.41%
HK:1877
Shanghai Junshi Biosciences Co., Ltd. Class H
21.38
10.78
101.70%
HK:1952
Everest Medicines Ltd.
38.96
-2.19
-5.32%
HK:2696
Shanghai Henlius Biotech, Inc. Class H
57.30
40.32
237.46%
HK:6855
Ascentage Pharma Group International
48.10
12.40
34.73%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts